Enphys Acquisition Corp.
NFYS · NYSE
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $169 | $216 | $237 | $255 |
| SG&A Expenses | $169 | $216 | $237 | $255 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $169 | $216 | $237 | $255 |
| Operating Income | $0 | -$216 | -$237 | -$255 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $1,213 | $763 | $2,254 | $4,184 |
| Pre-Tax Income | $1,034 | $548 | $2,017 | $3,929 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | $1,034 | $548 | $2,017 | $3,929 |
| % Margin | – | – | – | – |
| EPS | 0.063 | 0.034 | 0.087 | 0.091 |
| % Growth | 88.7% | -61.4% | -4.5% | – |
| EPS Diluted | 0.073 | 0.034 | 0.087 | 0.091 |
| Weighted Avg Shares Out | 16,311 | 16,311 | 23,196 | 43,125 |
| Weighted Avg Shares Out Dil | 14,133 | 16,312 | 23,196 | 43,125 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $1,753 | $4,707 |
| Interest Expense | $10 | $7 | $25 | $0 |
| Depreciation & Amortization | $0 | $216 | $237 | $255 |
| EBITDA | -$169 | $763 | $2,254 | -$255 |
| % Margin | – | – | – | – |